NCT02561273 2023-12-13
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
University of Nebraska
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Enteropathy-Associated T-Cell Lymphoma × Peripheral Blood Stem Cell Transplantation × Clear all